← Leaderboards
Linda A Sherman
Scripps Research Institute
$22,265,971
Attributed
$22,265,971
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$29,084,198 · 10
By mechanism
R01$9,978,923 · 2
U01$9,230,587 · 2
P01$8,146,363 · 3
R21$989,225 · 2
R56$739,100 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAutoantigensAntigensT-LymphocyteBaseMolecularTransgenic OrganismsPathway InteractionsPreventResearch StudyCd8b1 GeneAutoimmunityAllelesProteinsGene ExpressionPeptidesLymph NodesPhenotypeIsletDiabetes MellitusGenetically Modified AnimalsDisease SusceptibilityImmuneCell Type
Grant awards (56)
PTPN22 R619W in NOD mice$745,163
U01 · FY2021 · AI · contact PI
PTPN22 R619W in NOD mice$745,163
U01 · FY2020 · AI · contact PI
PTPN22 R619W in NOD mice$745,163
U01 · FY2019 · AI · contact PI
PTPN22 R619W in NOD mice$745,163
U01 · FY2018 · AI · contact PI
PTPN22 R619W in NOD mice$81,436
U01 · FY2018 · AI · contact PI
PTPN22 R619W in NOD mice$762,655
U01 · FY2017 · AI · contact PI
Creating Mouse Models to Study the Link Betwee PTPN22 and ACPA+ RA$211,750
R21 · FY2017 · AR · contact PI
PTPN22 R619W in NOD mice$739,100
R56 · FY2016 · AI · contact PI
Creating Mouse Models to Study the Link Betwee PTPN22 and ACPA+ RA$254,100
R21 · FY2016 · AR · contact PI
Mutant PTPN22 in autoimmune mice$144,375
R21 · FY2016 · AI · contact PI
Mutant PTPN22 in autoimmune mice$379,000
R21 · FY2015 · AI · contact PI
Peripheral CD8+ T Cell Tolerance$373,182
R01 · FY2014 · DK · contact PI
Peripheral CD8+ T Cell Tolerance$360,121
R01 · FY2013 · DK · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$389,284
R01 · FY2012 · CA · contact PI
Peripheral CD8+ T Cell Tolerance$373,182
R01 · FY2012 · DK · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$833,614
U01 · FY2011 · AI · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$389,284
R01 · FY2011 · CA · contact PI
Peripheral CD8+ T Cell Tolerance$373,182
R01 · FY2011 · DK · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$834,564
U01 · FY2010 · AI · contact PI
Peripheral CD8+ T Cell Tolerance$474,750
R01 · FY2010 · DK · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$401,323
R01 · FY2010 · CA · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$115,203
U01 · FY2010 · AI · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$703,237
U01 · FY2009 · AI · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$625,000
U01 · FY2009 · AI · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$401,323
R01 · FY2009 · CA · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$793,076
U01 · FY2008 · AI · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$401,323
R01 · FY2008 · CA · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$771,346
U01 · FY2007 · AI · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$481,518
R01 · FY2007 · CA · contact PI
Peripheral CD8+ T Cell Tolerance$391,542
R01 · FY2007 · DK · contact PI
Effects of insulin-dependent diabetes resistance alleles on CD8 tolerance in NOD$729,804
U01 · FY2006 · AI · contact PI
Generating CTL Against Tumor Associated Peptide Antigens$495,899
R01 · FY2006 · CA · contact PI
Peripheral CD8+ T Cell Tolerance$403,236
R01 · FY2006 · DK · contact PI
Peripheral CD8+ T Cell Tolerance$412,940
R01 · FY2005 · DK
Generating CTL Against Tumor Associated Peptide Antigens$355,534
R01 · FY2005 · CA
MODULATION OF EFFECTOR T CELLS IN DIABETES$1,387,317
P01 · FY2004 · DK
Peripheral CD8+ T Cell Tolerance$412,940
R01 · FY2004 · DK
GENERATING CTL AGAINST TUMOR ASSOCIATED PEPTIDE ANTIGENS$333,360
R01 · FY2004 · CA
MODULATION OF EFFECTOR T CELLS IN DIABETES$1,387,317
P01 · FY2003 · DK
PERIPHERAL CD8+ T CELL TOLERANCE$370,400
R01 · FY2003 · DK
GENERATING CTL AGAINST TUMOR ASSOCIATED PEPTIDE ANTIGENS$333,360
R01 · FY2003 · CA
MODULATION OF EFFECTOR T CELLS IN DIABETES$1,387,317
P01 · FY2002 · DK
PERIPHERAL CD8+ T CELL TOLERANCE$370,400
R01 · FY2002 · DK
GENERATING CTL AGAINST TUMOR ASSOCIATED PEPTIDE ANTIGENS$333,360
R01 · FY2002 · CA
Core--Transgenic mouse$221,356
P01 · FY2002 · DK
Low affinity CD8+ T cells in diabetes$221,356
P01 · FY2002 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES$1,328,138
P01 · FY2001 · DK
PERIPHERAL CD8+ T CELL TOLERANCE$354,600
R01 · FY2001 · DK
GENERATING CTL AGAINST TUMOR ASSOCIATED PEPTIDE ANTIGENS$319,140
R01 · FY2001 · CA
Core--Transgenic mouse$221,356
P01 · FY2001 · DK
Low affinity CD8+ T cells in diabetes$221,356
P01 · FY2001 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES$1,328,138
P01 · FY2000 · DK
PERIPHERAL CD8+ T CELL TOLERANCE$354,600
R01 · FY2000 · DK
GENERATING CTL AGAINST TUMOR ASSOCIATED PEPTIDE ANTIGENS$319,140
R01 · FY2000 · CA
Core--Transgenic mouse$221,356
P01 · FY2000 · DK
Low affinity CD8+ T cells in diabetes$221,356
P01 · FY2000 · DK